Leerdoelen: update leverchirurgie

Programma:

08.00-08.55 Registration, coffee and tea
08.55-09.00 Welcome T. van Gulik, A. Guglielmi

New horizons in molecular analysis of CCA (9.00-10.40)

Chairs: G. Kazemier, M. van de Vijver

09.00-09.20 How Next-Generation-Sequencing is going to change our management of CCA M. van de Vijver

09:20-09.40 Mutational profiling of CCA: a systematic review and meta-analysis E. Roos

09.40-10.00 The role of DNA-methylation in the epigenetics of CCA B. Goeppert

10.00-10.20 Do we need to standardize pathological assessment of the specimen J. Verheij

10.20-10.40 IgG4 related cholangitis mimicking PHC U. Beuers

10.40-11.10 Coffee-break

Management of intrahepatic CCA (IHC) (11.10-12.50) Chairs: H. Lang, B. Groot Koerkamp

11.10-11.30 Outcomes of resection in IHC H. Lang

11.30-11.50 Laparoscopic approach for resection of IHC M. Besselink

11.50-12.10 Hepatic arterial infusion chemotherapy in unresectable IHC B. Groot Koerkamp

12.10-12.30 Treatment with SIRT in unresectable IHC; the SIRCCA study H.J. Klümpen

12.30-12.50 Staging and risk score assessment in CCA J. Wiggers

12.50-13.30 Lunch

Preoperative biliary drainage in PHC (13.30-14.10)

Chairs: C. Iacono, O. Busch

Endoscopic or percutaneous preoperative biliary drainage?

13.30-13.50 Results of the DRAINAGE RCT R.J. Coelen

13.50-13.55 Comments from the endoscopist E. Rauws

13.55-14.00 Comments from the interventional radiologist K. van Lienden

14.00-14.10 Discussion

Surgical approaches to PHC (14.10-15.10)

Chairs: A. Guglielmi, M. Malago

14.10-14.30 When West meets East; why do outcomes differ? T. van Gulik

14.30-14.50 Outcomes of concomitant hepatic artery resection and reconstruction T. Noji

14.50-15.10 Concomitant portal vein resection; standard or selective? J. Pratschke

15.10-15.40 Tea-break

Surgical approaches to PHC (15.40-17.00)

Chairs: J. Primrose, M. Besselink

15.40-16.00 The Verona experience A. Guglielmi 16.00-16.20 Is there a place for ALPPS in resection of PHC? M. Malago

16.20-16.40 Adjuvant chemotherapy after resection of CCA. Which agent(s) should we use? J. Primrose

16.40-17.00 The European collaborative in PHC P. Olthof